Hidemi Ishii Selected Research

M55551

1/2006

Pharmacological characterization of the active synthetic factor Xa inhibitors M55551 and M55165.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hidemi Ishii Research Topics

Disease

4	Blister (Bulla) 11/2011 - 12/2006
3	Thrombosis (Thrombus) 09/2006 - 05/2004
2	Hepatocellular Carcinoma (Hepatoma) 06/2013 - 07/2012
2	Hemorrhage 09/2012 - 01/2006
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2011 - 12/2010
2	Inflammation (Inflammations) 09/2006 - 11/2002
1	Vascular Calcification 03/2013
1	Hyperphosphatemia 03/2013
1	Sepsis (Septicemia) 05/2009
1	Endotoxemia 05/2009
1	Fibrosarcoma 02/2009
1	Neoplasms (Cancer) 02/2009
1	Glomerulonephritis 01/2007
1	Edema (Dropsy) 01/2007
1	Atherosclerotic Plaque (Atheroma) 09/2003
1	Acute Monocytic Leukemia (Acute Monoblastic Leukemia) 11/2002
1	Acute Lung Injury 10/2002
1	Fibrosis (Cirrhosis) 10/2002

Drug/Important Bio-Agent (IBA)

4	Glutathione (Reduced Glutathione)IBA 11/2011 - 12/2006
4	Adenosine Triphosphate (ATP)IBA 11/2011 - 12/2006
4	Glutathione Disulfide (GSSG)FDA LinkGeneric 11/2011 - 12/2006
3	AntigensIBA 06/2013 - 09/2006
3	7- amino- 2- (((2- methyl- 1- (3- phenylpropanoylamino)propyl)hydroxyphosphinoyl)methyl)heptanoic acidIBA 05/2009 - 05/2004
3	ThrombomodulinIBA 02/2009 - 11/2002
2	Messenger RNA (mRNA)IBA 07/2012 - 09/2006
2	Proteins (Proteins, Gene)FDA Link 11/2011 - 12/2010
2	Malondialdehyde (Propanedial)IBA 11/2011 - 12/2006
2	Sulfhydryl Compounds (Thiols)IBA 11/2011 - 12/2010
2	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 05/2009 - 02/2009
1	nobiletinIBA 06/2013
1	FlavonoidsIBA 06/2013
1	ErbB Receptors (EGF Receptor)IBA 03/2013
1	Adenine FDA LinkGeneric 03/2013
1	AnticoagulantsIBA 09/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2012
1	FullerenesIBA 11/2011
1	hydroxide ionIBA 11/2011
1	AlkaloidsIBA 12/2010
1	Carbolines (Beta-Carbolines)IBA 12/2010
1	HarmalineIBA 12/2010
1	Harmine (Telepathine)IBA 12/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2009
1	FibrinIBA 05/2009
1	Ceftazidime (Fortum)FDA LinkGeneric 05/2009
1	LipopolysaccharidesIBA 05/2009
1	Fibrinogen (Factor I)FDA Link 05/2009
1	Thrombin Receptors (Thrombin Receptor)IBA 02/2009
1	PlasminogenIBA 02/2009
1	Prothrombin (Factor II)IBA 02/2009
1	N- methyl- 1- (1,3- benzodioxol- 5- yl)- 2- butanamine (MBDB)IBA 01/2009
1	Adenine NucleotidesIBA 01/2009
1	Carboxypeptidase BIBA 01/2007
1	NitrogenIBA 01/2007
1	Urea (Carbamide)FDA LinkGeneric 01/2007
1	FructoseIBA 12/2006
1	nitrosofenfluramineIBA 12/2006
1	SuspensionsIBA 12/2006
1	Thromboplastin (Tissue Factor)IBA 09/2006
1	Shiga Toxin (Shigella Toxin)IBA 09/2006
1	Factor Xa InhibitorsIBA 01/2006
1	argatroban (MPQA)FDA Link 01/2006
1	Warfarin (Coumadin)FDA LinkGeneric 01/2006
1	M55165IBA 01/2006
1	M55551IBA 01/2006
1	AcidsIBA 05/2004
1	Phosphinic Acids (Phosphinic Acid)IBA 05/2004
1	PPAR gammaIBA 11/2002
1	2,4-thiazolidinedione (thiazolidinedione)IBA 11/2002
1	LigandsIBA 11/2002
1	Pioglitazone (Actos)FDA Link 11/2002
1	Protein CIBA 11/2002
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2002

Therapy/Procedure

1	Therapeutics 09/2012
1	Intravenous Injections 05/2009
1	Oral Administration 01/2006
1	Intravenous Administration 01/2006